Sheena K Aurora

2PUBLICATIONS
0CO-AUTHORS
Pharmaceutical delivery technologiesFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 07, 2021
STOP 301: A Phase 3, open-label study of safety, tolerability, and exploratory efficacy of INP104, Precision Olfactory Delivery (POD® ) of dihydroergotamine mesylate, over 24/52 weeks in acute treatment of migraine attacks in adult patients.

Timothy R Smith, Paul Winner, Sheena K Aurora

|Apr 01, 2021
A link between gastrointestinal disorders and migraine: Insights into the gut-brain connection.

Sheena K Aurora, Stephen B Shrewsbury, Sutapa Ray

Pageof 1

Frequent Collaborators